Wentao Ni

2.8k total citations · 1 hit paper
47 papers, 2.0k citations indexed

About

Wentao Ni is a scholar working on Molecular Medicine, Pharmacology and Epidemiology. According to data from OpenAlex, Wentao Ni has authored 47 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Medicine, 20 papers in Pharmacology and 15 papers in Epidemiology. Recurrent topics in Wentao Ni's work include Antibiotic Resistance in Bacteria (26 papers), Antibiotics Pharmacokinetics and Efficacy (20 papers) and Pharmaceutical and Antibiotic Environmental Impacts (9 papers). Wentao Ni is often cited by papers focused on Antibiotic Resistance in Bacteria (26 papers), Antibiotics Pharmacokinetics and Efficacy (20 papers) and Pharmaceutical and Antibiotic Environmental Impacts (9 papers). Wentao Ni collaborates with scholars based in China, Philippines and United States. Wentao Ni's co-authors include Junchang Cui, You-ning Liu, Zhancheng Gao, Jin Zhao, Jing Bao, Chuanqi Wei, Xiuwen Yang, Deqing Yang, Yu Xu and Donghong Yang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Wentao Ni

44 papers receiving 2.0k citations

Hit Papers

Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19 2020 2026 2022 2024 2020 250 500 750

Peers

Wentao Ni
Wentao Ni
Citations per year, relative to Wentao Ni Wentao Ni (= 1×) peers Shio‐Shin Jean

Countries citing papers authored by Wentao Ni

Since Specialization
Citations

This map shows the geographic impact of Wentao Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wentao Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wentao Ni more than expected).

Fields of papers citing papers by Wentao Ni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wentao Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wentao Ni. The network helps show where Wentao Ni may publish in the future.

Co-authorship network of co-authors of Wentao Ni

This figure shows the co-authorship network connecting the top 25 collaborators of Wentao Ni. A scholar is included among the top collaborators of Wentao Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wentao Ni. Wentao Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Fang, Hongyu Ren, Wentao Ni, et al.. (2024). A case report of severe pulmonary legionellosis caused by Legionella bozemanae. SHILAP Revista de lepidopterología. 3.
2.
Xin, Yue, Ran Li, Keqiang Wang, et al.. (2024). Analysis and Validation of a Diagnostic Nomogram for Predicting the Risk of Acute Respiratory Failure for Non-HIV Related Pneumocystis Jirovecii Pneumonia Patients. Risk Management and Healthcare Policy. Volume 17. 2971–2980. 1 indexed citations
3.
Wang, Meiling, et al.. (2023). Discovery of Fibrinogen γ-chain as a potential urinary biomarker for renal interstitial fibrosis in IgA nephropathy. BMC Nephrology. 24(1). 60–60. 5 indexed citations
4.
Shi, Xudong, et al.. (2023). Total body bone mineral density and various spinal disorders: a Mendelian randomization study. Frontiers in Endocrinology. 14. 1285137–1285137. 1 indexed citations
5.
Wang, Chuanhai, et al.. (2022). Cefiderocol for the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review of Currently Available Evidence. Frontiers in Pharmacology. 13. 896971–896971. 46 indexed citations
6.
Ma, Xinqian, Lili Zhao, Yukun He, et al.. (2022). Heteroresistance Is Associated With in vitro Regrowth During Colistin Treatment in Carbapenem-Resistant Klebsiella pneumoniae. Frontiers in Microbiology. 13. 868991–868991. 16 indexed citations
7.
Ni, Wentao, Yifan Wang, Xinqian Ma, et al.. (2022). In vitro and in vivo efficacy of cefiderocol plus tigecycline, colistin, or meropenem against carbapenem-resistant Acinetobacter baumannii. European Journal of Clinical Microbiology & Infectious Diseases. 41(12). 1451–1457. 14 indexed citations
8.
Ni, Wentao, Xiuwen Yang, Jie Liu, et al.. (2020). Acute Myocardial Injury at Hospital Admission Is Associated With All-Cause Mortality in COVID-19. Journal of the American College of Cardiology. 76(1). 124–125. 56 indexed citations
9.
Ni, Wentao, Guobao Li, Jin Zhao, et al.. (2018). In vitro activity of minocycline combined with aminoglycosides against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. The Journal of Antibiotics. 71(5). 506–513. 12 indexed citations
10.
Ni, Wentao, et al.. (2016). In vitro activity of antibiotic combination against carbapenems-resistant Pseudomonas aeruginosa. 32(24). 2276. 2 indexed citations
11.
Zhao, Jin, Yubin Xing, Wei Liu, et al.. (2016). Surveillance of Dihydropteroate Synthase Genes in Stenotrophomonas maltophilia by LAMP: Implications for Infection Control and Initial Therapy. Frontiers in Microbiology. 7. 1723–1723. 8 indexed citations
12.
Ni, Wentao, Yuliang Han, Jin Zhao, et al.. (2016). Serum soluble urokinase-type plasminogen activator receptor as a biological marker of bacterial infection in adults: a systematic review and meta-analysis. Scientific Reports. 6(1). 39481–39481. 45 indexed citations
14.
Ni, Wentao, Yuliang Han, Chuanqi Wei, et al.. (2016). Tigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections. Medicine. 95(11). e3126–e3126. 88 indexed citations
15.
Ni, Wentao, Chuanqi Wei, Beibei Liang, et al.. (2016). Tigecycline-Amikacin Combination Effectively Suppresses the Selection of Resistance in Clinical Isolates of KPC-Producing Klebsiella pneumoniae. Frontiers in Microbiology. 7. 1304–1304. 19 indexed citations
16.
Ni, Wentao, Yuliang Han, Jin Zhao, et al.. (2015). Tigecycline treatment experience against multidrug-resistant Acinetobacter baumannii infections: a systematic review and meta-analysis. International Journal of Antimicrobial Agents. 47(2). 107–116. 77 indexed citations
17.
Ni, Wentao, et al.. (2015). Efficacy of polymyxins in the treatment of carbapenem-resistant Enterobacteriaceae infections: a systematic review and meta-analysis. The Brazilian Journal of Infectious Diseases. 19(2). 170–180. 32 indexed citations
18.
Ni, Wentao, et al.. (2014). In vitro synergy of polymyxins with other antibiotics for Acinetobacter baumannii: A systematic review and meta-analysis. International Journal of Antimicrobial Agents. 45(1). 8–18. 100 indexed citations
19.
Ni, Wentao, et al.. (2014). Effect of Proton Pump Inhibitors on In Vitro Activity of Tigecycline against Several Common Clinical Pathogens. PLoS ONE. 9(1). e86715–e86715. 16 indexed citations
20.
Ni, Wentao, Junchang Cui, Beibei Liang, et al.. (2013). In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii. The Journal of Antibiotics. 66(12). 705–708. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026